Fosaprepitant
- Product NDC
- 16714-929
- 11-digit product format
- 167140929
- Labeler code
- 16714
- Product ID
- 16714-929_aaa387b8-d77a-432f-5989-a4f67bf0e3be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fosaprepitant
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- NorthStar RxLLC
- Application
- ANDA209965
- Marketing category
- ANDA
- Marketing start
- 2020-03-20
- Marketing end
- 0000-00-00
- Substance
- FOSAPREPITANT DIMEGLUMINE
- Active strength
- 150 mg/5mL
- Pharmacologic classes
- Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-929-01 | 16714092901 | 1 VIAL in 1 CARTON (16714-929-01) > 1 mL in 1 VIAL | 1 vial | 2020-03-20 | 0000-00-00 | No | No | Current |